INNOVATIVE EYEWEAR INC (LUCY) Fundamental Analysis & Valuation
NASDAQ:LUCY • US45791D2080
Current stock price
1.07 USD
-0.05 (-4.46%)
At close:
1.07 USD
0 (0%)
After Hours:
This LUCY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. LUCY Profitability Analysis
1.1 Basic Checks
- LUCY had negative earnings in the past year.
- In the past year LUCY has reported a negative cash flow from operations.
- LUCY had negative earnings in each of the past 5 years.
- LUCY had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- LUCY has a Return On Assets of -70.22%. This is in the lower half of the industry: LUCY underperforms 73.40% of its industry peers.
- LUCY has a Return On Equity (-76.56%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.22% | ||
| ROE | -76.56% | ||
| ROIC | N/A |
ROA(3y)-102.4%
ROA(5y)-213.8%
ROE(3y)-115.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 22.83%, LUCY is doing worse than 78.72% of the companies in the same industry.
- In the last couple of years the Gross Margin of LUCY has declined.
- LUCY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.43%
GM growth 5YN/A
2. LUCY Health Analysis
2.1 Basic Checks
- LUCY does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for LUCY has been increased compared to 1 year ago.
- LUCY has less shares outstanding than it did 5 years ago.
- There is no outstanding debt for LUCY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- LUCY has an Altman-Z score of -1.26. This is a bad value and indicates that LUCY is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -1.26, LUCY is doing worse than 60.11% of the companies in the same industry.
- LUCY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.26 |
ROIC/WACCN/A
WACC10.28%
2.3 Liquidity
- A Current Ratio of 11.98 indicates that LUCY has no problem at all paying its short term obligations.
- LUCY has a better Current ratio (11.98) than 96.28% of its industry peers.
- A Quick Ratio of 10.13 indicates that LUCY has no problem at all paying its short term obligations.
- LUCY has a better Quick ratio (10.13) than 94.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 11.98 | ||
| Quick Ratio | 10.13 |
3. LUCY Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 72.66% over the past year.
- Looking at the last year, LUCY shows a very strong growth in Revenue. The Revenue has grown by 53.21%.
- LUCY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.36% yearly.
EPS 1Y (TTM)72.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.62%
Revenue 1Y (TTM)53.21%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%163.46%
3.2 Future
- LUCY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.67% yearly.
- LUCY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 117.64% yearly.
EPS Next Y71.92%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year52.63%
Revenue Next 2Y117.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. LUCY Valuation Analysis
4.1 Price/Earnings Ratio
- LUCY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year LUCY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- LUCY's earnings are expected to grow with 36.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.67%
EPS Next 3YN/A
5. LUCY Dividend Analysis
5.1 Amount
- No dividends for LUCY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LUCY Fundamentals: All Metrics, Ratios and Statistics
1.07
-0.05 (-4.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)N/A N/A
Inst Owners7.33%
Inst Owner Change5.36%
Ins Owners9.03%
Ins Owner Change-16.59%
Market Cap5.72M
Revenue(TTM)2.39M
Net Income(TTM)-7.85M
Analysts82.86
Price Target3.06 (185.98%)
Short Float %2.94%
Short Ratio0.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.97%
Min EPS beat(2)15.97%
Max EPS beat(2)23.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-38.87%
Min Revenue beat(2)-43.24%
Max Revenue beat(2)-34.5%
Revenue beat(4)0
Avg Revenue beat(4)-41.35%
Min Revenue beat(4)-55.39%
Max Revenue beat(4)-32.28%
Revenue beat(8)1
Avg Revenue beat(8)-18.57%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.39 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.56 | ||
| P/tB | 0.58 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.63
EYN/A
EPS(NY)-1.05
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.47
OCFYN/A
SpS0.45
BVpS1.92
TBVpS1.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.22% | ||
| ROE | -76.56% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.83% | ||
| FCFM | N/A |
ROA(3y)-102.4%
ROA(5y)-213.8%
ROE(3y)-115.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.43%
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 89.89% | ||
| Cap/Sales | 5.5% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 11.98 | ||
| Quick Ratio | 10.13 | ||
| Altman-Z | -1.26 |
F-Score3
WACC10.28%
ROIC/WACCN/A
Cap/Depr(3y)402.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)23.82%
Cap/Sales(5y)37.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.62%
EPS Next Y71.92%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)53.21%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%163.46%
Revenue Next Year52.63%
Revenue Next 2Y117.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-29.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.43%
OCF growth 3YN/A
OCF growth 5YN/A
INNOVATIVE EYEWEAR INC / LUCY Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for INNOVATIVE EYEWEAR INC?
ChartMill assigns a fundamental rating of 4 / 10 to LUCY.
Can you provide the valuation status for INNOVATIVE EYEWEAR INC?
ChartMill assigns a valuation rating of 1 / 10 to INNOVATIVE EYEWEAR INC (LUCY). This can be considered as Overvalued.
What is the profitability of LUCY stock?
INNOVATIVE EYEWEAR INC (LUCY) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for LUCY stock?
The Earnings per Share (EPS) of INNOVATIVE EYEWEAR INC (LUCY) is expected to grow by 71.92% in the next year.